EXAS up +3.20% percent Today $EXAS High is at 23.32 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 13, 2014 at 1:52 PM

EXAS up +3.20% percent Today $EXAS High is at 23.32 and the Low 22.50 with current volume of 166,190.

Recent News posted below.

Exact Sciences Corp EXAS other info.
http://investorshangout.com/Exact-Sciences-Corp-EXAS-54061/

EXAS Exact Sciences Corp Recent Headline News

Cologuard(R) Wins Popular Science Magazine's 2014 "Best of What's New" Award
Business Wire - Wed Nov 12, 11:30AM CST
Exact Sciences Corp. (NASDAQ: EXAS) today announced Cologuard has received a 2014 "Best of What's New" award from Popular Science.
EXAS: 23.19 (+0.69)

Exact Sciences Earnings In Retrospect: Down 3.3% in the Last 14 Days (EXAS)
Comtex SmarTrend(R) - Mon Nov 10, 1:05PM CST
Two weeks ago on October 27th, 2014 Exact Sciences (NASDAQ:EXAS) reported earnings and analysts, on average, expected a loss of $0.32 on sales of $156.0 thousand. Exact Sciences actually reported a loss of $0.39 per share on sales of $0.0 thousand, missing EPS estimates by $0.07 and matching revenue estimates. Since the company's report, shares of Exact Sciences have fallen from $23.61 to $22.82, representing a loss of 3.3% in the past 14 days.
EXAS: 23.19 (+0.69)

VYCOR: "On the Cusp of the Next Big Healthcare Trend"
ACCESSWIRE - Mon Nov 10, 8:23AM CST
Vycor: "On the Cusp of the Next Big Healthcare Trend"
MDVN: 106.51 (+0.18), ABMD: 33.24 (-0.36), JNJ: 108.53 (-0.22), AMGN: 160.04 (-1.89), EXAS: 23.19 (+0.69), ARAY: 7.04 (-0.01), HOLX: 26.45 (-0.10), PBYI: 236.75 (+0.63)

Technical Pulse on Biotech Stocks - Dendreon, Alkermes, Exact Sciences, Inovio Pharma, and Seattle Genetics
PR Newswire - Mon Nov 10, 8:05AM CST
Investor-Edge has initiated coverage on the following equities: Dendreon Corporation (NASDAQ: DNDN), Alkermes PLC (NASDAQ: ALKS), Exact Sciences Corporation (NASDAQ: EXAS), Inovio Pharmaceuticals Inc. (NASDAQ: INO), and Seattle Genetics Inc. (NASDAQ: SGEN). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Friday, November 07, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,573.93, up 0.11% and the NASDAQ Composite closed at 4,632.53, down 0.13%. The S&P 500 finished the session 0.03% higher at 2,031.92. During the trading session, seven out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 775.27, down 0.94%, whereas the index has gained 10.75% in the previous three months. Register for your complimentary reports on these five stocks at:
INO: 11.01 (-0.09), SGEN: 36.95 (-0.85), DNDN: 0.13 (-0.03), EXAS: 23.19 (+0.69), ALKS: 52.56 (-0.44)

MDXHealth - Piggybacking On Exact Sciences' Cologuard Success
SNJBiostoxx - at Seeking Alpha - Thu Nov 06, 10:43AM CST

EXAS: 23.19 (+0.69)

American Cancer Society Includes Exact Sciences' Cologuard in Colorectal Cancer Prevention and Early Detection Guidelines
Business Wire - Thu Nov 06, 7:02AM CST
Exact Sciences Corp. (NASDAQ: EXAS) today announced that the American Cancer Society's Colorectal Cancer Prevention and Early Detection national guidelines for colorectal cancer screening now reflect the commercial availability of Cologuard, the company's noninvasive stool DNA colorectal cancer screening test.
EXAS: 23.19 (+0.69)

Exact Sciences to Participate in November Conferences
Business Wire - Wed Nov 05, 3:31PM CST
Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will participate in three investor conferences during November.
EXAS: 23.19 (+0.69)

Using Existing Technology To Anticipate Adoption Of Exact Sciences' Cologuard Test
Doug Van Cuyk - at Seeking Alpha - Tue Nov 04, 12:04PM CST

EXAS: 23.19 (+0.69)

Exact Sciences lowers earnings 187% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 12:08PM CST

EXAS: 23.19 (+0.69)

Exact Sciences: Q3 Marketing Efforts Look Promising
AlphaIdeas - at Seeking Alpha - Wed Oct 29, 4:22PM CDT

EXAS: 23.19 (+0.69)

Exact Sciences Announces Meriter-UnityPoint Health Now Offering Cologuard(R)
Business Wire - Wed Oct 29, 8:00AM CDT
Exact Sciences Corp. (NASDAQ: EXAS) today announced that Meriter-UnityPoint Health will now offer Cologuard(R), the first and only FDA approved noninvasive stool DNA screening test for colorectal cancer.
EXAS: 23.19 (+0.69)

Downgrade Alert for Exact Sciences (EXAS)
Comtex SmarTrend(R) - Tue Oct 28, 7:04AM CDT
Exact Sciences (NASDAQ:EXAS) was downgraded from Overweight to Equal Weight at Stephens today. The stock closed yesterday at $23.61 on volume of 2.4 million shares, below average daily volume of 2.5 million. Exact Sciences (NASDAQ:EXAS) is currently priced 20.7% above its average consensus analyst price target of $18.73. The stock should discover initial support at its 50-day moving average (MA) of $20.89 and subsequent support at its 200-day MA of $15.94.
EXAS: 23.19 (+0.69)

EXACT Sciences' (EXAS) CEO Kevin Conroy on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Oct 27, 3:19PM CDT

EXAS: 23.19 (+0.69)

EXACT Sciences (EXAS) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Oct 27, 8:55AM CDT

EXAS: 23.19 (+0.69)

Exact Sciences Q3 expenses up 155% at it prepares for Cologuard launch
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 7:49AM CDT

EXAS: 23.19 (+0.69)

EXACT Sciences misses by $0.07
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 6:38AM CDT

EXAS: 23.19 (+0.69)

Exact Sciences misses 3Q profit forecasts
Automated Insights - Mon Oct 27, 6:36AM CDT
MADISON, Wis. (AP) _ Exact Sciences Corp. (EXAS) on Monday reported a third-quarter loss of $32.1 million.
EXAS: 23.19 (+0.69)

Exact Sciences Reports Third-Quarter 2014 Financial Results
Business Wire - Mon Oct 27, 6:30AM CDT
Exact Sciences Corp. (Nasdaq:EXAS) today announced its financial results for the quarter ended Sept. 30, 2014.
EXAS: 23.19 (+0.69)

Notable earnings before Monday’s open
Seeking Alpha - at Seeking Alpha - Sun Oct 26, 4:30PM CDT

ROP: 156.48 (-0.28), SIR: 24.22 (+0.01), VNDA: 12.37 (-0.45), STX: 61.74 (-0.58), NMM: 13.26 (-0.47), LGND: 57.96 (+0.26), PDS: 7.63 (-0.32), TREX: 43.04 (-1.10), EXAS: 23.19 (+0.69), AWI: 49.31 (+0.18), EDR: 11.53 (+0.03), HUN: 25.05 (+0.16), TEN: 56.18 (+1.01), AGN: 196.25 (-0.26), ONB: 14.84 (-0.18), STNG: 8.75 (-0.25), MRK: 59.22 (-0.09), BEN: 56.55 (-0.42)

NewLink Genetics Corporation (NLNK) in Focus: Stock Soars 15.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 8:18AM CDT
NewLink Genetics Corporation (NLNK) was a big mover last session, as the company saw its shares rise by over 15% on the day.
HALO: 8.81 (-0.17), NLNK: 31.19 (-1.20), ILMN: 184.77 (-2.15), EXAS: 23.19 (+0.69)

Exact Sciences Corp. (EXAS) Stock Research Links

EXAS Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elong Kicks Off Central Asia Strategy with Almaty Launch

Elong's Strategic Move into Central Asia When a company like Elong Hotel Technology decides to plant its flag in Central Asia, it’s more than just another overseas venture. This brand launch in Almaty is a bold statement—a signal that they're here to shake things up in a region ripe for development but lacking in hotel chains. With only about 20% penetration for local...

AptarGroup Faces Investigation: Shareholder Stakes High

AptarGroup Directors Under Investigation Every seasoned investor knows the market isn’t just sunshine and rainbows. Lately, the storm clouds have gathered over AptarGroup, Inc. (NYSE: ATR). Out of nowhere comes Purcell & Lefkowitz LLP, announcing a shareholder investigation that sends shivers down the spines of those who've put their money on this packaging...

24X Partners with Standard Chartered for Crypto Leap

24X Steps Up the Game with Crypto Addition You gotta give it to 24X—they're not just twiddling their thumbs in the background. These folks in Bermuda have snagged another feather in their cap by expanding their partnership with heavyweight Standard Chartered, bringing Bitcoin and Ethereum into the mix. We're talking big moves here as 24X becomes the first to offer...

Cloud Software Group's $2B Debt Offer Wraps Up

Sizing Up Cloud Software Group’s Recent Maneuver Whoever thought navigating debt was a dull spectacle hasn’t kept up with Cloud Software Group's recent financial theatrics. With a $2 billion cap on the table, their cash tender offer for 9.00% Senior Secured Second Lien Notes due 2029 didn’t just happen; it paraded onto the financial stage and left a noteworthy...

Sino Biological Boosts AI Protein Discovery Efficiency

Dissecting the Bridge Between AI and Biology In the cutthroat world of biotech, every second counts. Sino Biological is taking a good hard look at bridging AI and practical applications with their shiny new 4RISE™ solution. The stakes couldn't be higher—turning computer-generated protein ideas into lab-tested realities is no small feat. And believe me, researchers...

VT Markets Unites Trading and Drama in New Finale

Trading Meets Reality Show Drama Just when you thought you'd seen it all in the trading world, VT Markets rolls out a new spectacle. They're launching the Gold Cup 2026, an unscripted reality show stuffed with enough drama and tension to keep any trader on the edge of their seat. This isn't your run-of-the-mill trading competition; this is an injection of pure adrenaline...

Poland's Economic Boom: A Case for Freedom and Growth

Poland's Remarkable Journey to Economic Power Freedom, they say, fuels progress—and Poland stands as a pulsating testament to that very idea. Thirty-odd years ago, shedding the chains of Soviet-imposed communism, Poland was all systems go, taking the wheel of its own destiny. For the first time, Polish innovation and industry were unleashed, paving the road toward...

Quantinuum & RIKEN Propel Japan's Quantum Leap Forward

Quantum Computing: Japan's Bold New Frontier Quantum computing's buzz is getting louder, and the big players like Quantinuum and RIKEN ain't sitting on their hands. They've rolled up their sleeves to ramp up Japan's quantum-AI supercomputing game with the recent beef-up of Quantinuum's Reimei to its H2 system, putting Japan at the cutting edge of hybrid computing. The...

AION Labs Elevates Leadership, Eyes New R&D Horizons

Setting New Standards in Pharma Innovation The air in Rehovot, Israel might be filled with more than just technological aspirations, thanks to AION Labs stepping up its leadership game. This venture studio doesn't seem content to rest on its laurels. Nope, it's diving headlong into the deeper end of pharma R&D, scouting out fresh tech territories like quantum computing...

1-800Accountant Secures Global Win in Tax Services

Another Feather in the Cap for 1-800Accountant You don’t get to be at the top of your game without turning a few heads. And 1-800Accountant has done just that, snagging the Fall 2026 Clutch Global Award for their expertise in the accounting universe. The Importance of Listening In this day and age, businesses large and small are realizing that the voice of the client is...